Generic-Drug Firms Fall as U.S. Threatens to Sue for Damages
- U.S. may sue as part of criminal investigation: official
- Shares of Mylan, Teva, Endo decline after the comments
Trump vs. Big Pharma: Can He Bring Drug Prices Down?
This article is for subscribers only.
Shares of generic-drug makers including Mylan NV and Teva Pharmaceutical Industries Ltd. fell after the Justice Department’s antitrust division said it might sue them for damages in a price-fixing probe.
If taxpayers were overcharged because drugmakers conspired to raise the price of drugs, the Justice Department will consider suing to seek damages, Makan Delrahim, the division’s chief, said in remarks Friday at George Mason University’s law school in Virginia.